NO903007L - 6- og 7-deoksyforskolin samt derivater derav, mellomprodukter og fremgangsmaate for fremstilling derav, samt anvendelse som medikamenter. - Google Patents

6- og 7-deoksyforskolin samt derivater derav, mellomprodukter og fremgangsmaate for fremstilling derav, samt anvendelse som medikamenter.

Info

Publication number
NO903007L
NO903007L NO90903007A NO903007A NO903007L NO 903007 L NO903007 L NO 903007L NO 90903007 A NO90903007 A NO 90903007A NO 903007 A NO903007 A NO 903007A NO 903007 L NO903007 L NO 903007L
Authority
NO
Norway
Prior art keywords
deoxyforskolin
medicines
procedures
derivatives
production
Prior art date
Application number
NO90903007A
Other languages
English (en)
Norwegian (no)
Other versions
NO903007D0 (no
Inventor
Raymond Walter Kosley Jr
Bettina Spahl
Original Assignee
Hoechst Roussel Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Roussel Pharma filed Critical Hoechst Roussel Pharma
Publication of NO903007D0 publication Critical patent/NO903007D0/no
Publication of NO903007L publication Critical patent/NO903007L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/22—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4
    • C07D311/24—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/78—Ring systems having three or more relevant rings
    • C07D311/92—Naphthopyrans; Hydrogenated naphthopyrans

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Neurosurgery (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biomedical Technology (AREA)
  • Cardiology (AREA)
  • Neurology (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Ophthalmology & Optometry (AREA)
  • Pulmonology (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
NO90903007A 1989-07-06 1990-07-05 6- og 7-deoksyforskolin samt derivater derav, mellomprodukter og fremgangsmaate for fremstilling derav, samt anvendelse som medikamenter. NO903007L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/376,383 US5093336A (en) 1989-07-06 1989-07-06 6- and 7-deoxyforskolin and derivatives thereof

Publications (2)

Publication Number Publication Date
NO903007D0 NO903007D0 (no) 1990-07-05
NO903007L true NO903007L (no) 1991-01-07

Family

ID=23484803

Family Applications (1)

Application Number Title Priority Date Filing Date
NO90903007A NO903007L (no) 1989-07-06 1990-07-05 6- og 7-deoksyforskolin samt derivater derav, mellomprodukter og fremgangsmaate for fremstilling derav, samt anvendelse som medikamenter.

Country Status (13)

Country Link
US (1) US5093336A (hu)
EP (1) EP0406789A1 (hu)
JP (1) JPH0344385A (hu)
KR (1) KR910002830A (hu)
AU (1) AU5870190A (hu)
CA (1) CA2020542A1 (hu)
FI (1) FI903365A0 (hu)
HU (1) HUT55771A (hu)
IE (1) IE902437A1 (hu)
IL (1) IL94974A0 (hu)
NO (1) NO903007L (hu)
PT (1) PT94602A (hu)
ZA (1) ZA905263B (hu)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5646175A (en) * 1987-12-28 1997-07-08 Hoechst Marion Roussel, Inc. Carbamoyloxylabdane compounds
US4920146A (en) * 1986-12-29 1990-04-24 Hoechst Roussel Pharmaceuticals Inc. Carbamoyloxylabdane compounds useful in reducing intraocular pressure
US6737084B2 (en) 2000-06-27 2004-05-18 Qualilife Compositions and methods for enhancing or treating female sexual response

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2557784C2 (de) * 1975-12-22 1986-04-17 Hoechst Ag, 6230 Frankfurt Forskolin, Verfahren zu dessen Gewinnung und diese Verbindung enthaltende pharmazeutische Präparate
DE2640275A1 (de) * 1976-09-08 1978-03-09 Hoechst Ag Pharmakologisch wirksame substanz aus labiaten
DE2654796A1 (de) * 1976-12-03 1978-06-08 Hoechst Ag Polyoxygenierte labdan-derivate
US4517200A (en) * 1982-12-27 1985-05-14 Schering-Plough Corporation Method for treating allergic reactions with forskolin
US4564626A (en) * 1983-04-01 1986-01-14 Schering Corporation Methods of inducing bronchodilation
DE3314999A1 (de) * 1983-04-26 1985-03-14 Behringwerke Ag, 3550 Marburg Verwendung des diterpen-derivates forskolin zur immunstimulation
US4476140A (en) * 1983-05-16 1984-10-09 Yale University Composition and method for treatment of glaucoma
DE3407514A1 (de) * 1984-03-01 1985-09-26 Hoechst Ag, 6230 Frankfurt Verwendung von polyoxygenierten labdanderivaten zur behandlung von konstriktionen der atemwege
US4672115A (en) * 1984-12-14 1987-06-09 Hoechst-Roussel Pharmaceuticals Inc. Process for preparing aminoacyllabdanes
US4639446A (en) * 1984-12-14 1987-01-27 Hoechst-Roussel Pharmaceuticals Inc. Aminoacyllabdanes, pharmaceutical compositions and use
DE3502685A1 (de) * 1985-01-26 1986-09-04 Hoechst Ag, 6230 Frankfurt Forskolin, seine analoge und derivate, verfahren zu deren herstellung mittels mikrobieller umwandlungen und die anwendung dieser verbindungen als arzneimittel
US4666904A (en) * 1984-12-14 1987-05-19 Hoechst-Roussel Pharmaceuticals Inc. Aminoacyllabdanes, pharmacuetical compositions and use
US4673752A (en) * 1984-12-14 1987-06-16 Hoechst-Roussel Pharmaceuticals Inc. Aminoacyllabdanes
DE3502686A1 (de) * 1985-01-26 1986-08-14 Hoechst Ag, 6230 Frankfurt Verfahren zur herstellung von labdan-derivaten und ihre verwendung als arzneimittel
US4639443A (en) * 1985-03-01 1987-01-27 Hoechst-Roussel Pharmaceuticals Inc. Labdane compounds, pharmaceutical compositions and use
US4677103A (en) * 1985-03-01 1987-06-30 Hoechst-Roussel Pharmaceuticals Inc. Labdane compounds, pharmaceutical compositions and use
EP0193132B1 (en) * 1985-03-01 1991-04-17 Hoechst-Roussel Pharmaceuticals Incorporated Labdan-derivatives, a process for their preparation and their use as medicaments
US4871764A (en) * 1986-11-20 1989-10-03 Hoechst-Roussel Pharmaceuticals, Inc. 12-Halogenated forskolin derivatives
NZ223051A (en) * 1986-12-29 1990-06-26 Hoechst Roussel Pharma Carbamoyloxylabdane derivatives and pharmaceutical compositions
IN166900B (hu) * 1987-06-03 1990-08-04 Hoechst India

Also Published As

Publication number Publication date
NO903007D0 (no) 1990-07-05
US5093336A (en) 1992-03-03
CA2020542A1 (en) 1991-01-07
KR910002830A (ko) 1991-02-26
JPH0344385A (ja) 1991-02-26
PT94602A (pt) 1991-03-20
AU5870190A (en) 1991-02-07
HU904113D0 (en) 1990-12-28
HUT55771A (en) 1991-06-28
IL94974A0 (en) 1991-06-10
FI903365A0 (fi) 1990-07-04
ZA905263B (en) 1991-03-27
IE902437A1 (en) 1991-06-19
EP0406789A1 (en) 1991-01-09

Similar Documents

Publication Publication Date Title
FI873630A0 (fi) Stabilt farmaceutiskt preparat.
FI903028A0 (fi) Polymerbaserade blandningskompositioner, som innehaoller destrukturerad staerkelse.
FI895225A0 (fi) Foerfarande foer borttagning av tungmetaller, saerskilt kadmium, fraon loesningar som innehaoller fosforsyra.
NO902012D0 (no) Kaffeprodukt, samt fremgangsmaate for dets fremstilling.
FI880159A0 (fi) Foerfarande foer vaermekrackning av kolvaeten, vid vilket partikelformigt fast material anvaends som vaermeoeverfoeringsmedel.
FI900870A0 (fi) Foerfarande foer belaeggning av papper med kompositioner, som innehaoller mikrokapslar.
NO883465D0 (no) Fremgangsmaate og mellomprodukter for fremstilling av 1-fenyl-3-(1-piperazinyl)-1h-indazoler, og anvendelse derav som medikamenter.
NO904576L (no) Aminopyridinylaminofenol og beslektede forbindelser, mellomprodukter, fremgangsmaate for deres fremstilling og anvendelse som medikamenter.
FI884545A0 (fi) Farmaceutisk komposition, som innehaoller avsvaellande piperidinoalkanolfoereningar.
DK361288A (da) Hydroxyethylazolylderivater, deres fremstilling og anvendelse samt mellemprodukter til fremstilling og disses fremstilling
NO890096D0 (no) Pyrazol- og indozolpyridinaminer, en fremgangsmaate for fremstilling og anvendelse derav som medikamenter.
FI883342A0 (fi) Substituerade tienoimidazol-derivat, foerfarande foer deras framstaellning, dessa innehaollande farmaceutiska produkter och deras anvaendning som magsyrasekret hindrande aemnen, magsaecken skyddande aemnen samt vid behandling av tarminflammationer anvaendbara laekemedel.
FI904191A0 (fi) Nya aminopropanolderivater, foerfarande foer tillverkning av dessa samt farmaceutiska sammansaettningar som innehaoller dessa.
NO903007D0 (no) 6- og 7-deoksyforskolin samt derivater derav, mellomprodukter og fremgangsmaate for fremstilling derav, samt anvendelse som medikamenter.
FI896156A0 (fi) Produktionslinje foer glasrutor som skall boejas.
DK260884D0 (da) 7-oxo-4-thia-1-azabicyclo(3.2.0)-hept-2-en-derivater,fremgangsmaade til fremstilling deraf samt deres anvendelse som laegemidler
DE59001317D1 (de) Pdgf-a, pdgf-aa, pdgf-ab, herstellungsverfahren und sie enthaltende arzneimittel.
DK222888D0 (da) Anellerede heteroalkylenquinolinaminer, isomere og salte deraf, deres fremstilling og anvendelse som laegemidler smat mellemprodukter til fremstillingen
DE69003811D1 (de) Imidazopyrimidine, antiallergische heilmittel.
NO901628D0 (no) Vandige plastdispersjoner, samt fremgangsmaate for fremstilling av dem, og anvendelse.
NO900119D0 (no) Fremgangsmaate for fremstilling av 7-aryl- og heteroaryletere av desacetylforskolin, og deres anvendelse som medikamenter.
FI902902A0 (fi) Foerfarande foer framstaellning av flexibelt polyuretanskum medelst anvaendning av 1,1,1-trikloretan som skumaemne.
ES1008917Y (es) Soporte para botellas, frascos y similares.
NO912680D0 (no) Produksjonslinje for innbruddsgitter og innbruddsgitter produsert med samme.
ES1008227Y (es) Tapon-obturador para frascos monopieza.